Besides, Urquidi and collaborators reported a 3-protein biomarker panel (PAI-1, CD44 antigen and C-C motif chemokine 18 (CCL18)) to discriminate BC patients from healthy controls [204]. Here, SERPINE1 is linked to breast cancer.